Skip to content

Effects of RF Microneedle on Photoaging Skin

RF Microneedle Therapy Maintains the Treatment Effect of Melasma: A 32-week, Prospective, Randomized Split-face Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05710068
Enrollment
15
Registered
2023-02-02
Start date
2021-12-01
Completion date
2022-09-01
Last updated
2023-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pigmentation, Pigmentation Disorder

Brief summary

Melasma relapse is almost common after discontinuation of conventional treatment. Recent studies have suggested that photoaging dermis is main pathomechanism of melasma emphasizing stromal targeting therapy. Therefore, we investigated maintenance effect of microneedle radiofrequency (RF) for melasma treatment.

Interventions

DEVICERF Microneedle

Pulsed-type RF device in bipolar mode with 25 non-insulated microneedles every 2 weeks for 6 month

5% hydroquinone, 0.003% tretinoin, and 1% hydrocortisone twice daily for 2 months

Sponsors

Ajou University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

split lesion study

Eligibility

Sex/Gender
FEMALE
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult more than 19 years old * Melasma clinically diagnosed by three dermatologists

Exclusion criteria

* Aesthetic medical procedures in three months prior to the study * Use of topical depigmenting agents in three months prior to the study * Pregnant or lactating

Design outcomes

Primary

MeasureTime frameDescription
Change of modified melasma area severity index scoreEvery 1 month up to 8 monthsChange of modified melasma area severity index score
Change of lightness valueEvery 1 month up to 8 monthsChange of lightness value by a chromometer

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026